Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Beta blocker
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Blood–brain barrier permeability === Beta blockers vary in their [[lipophilicity]] (fat solubility) and in turn in their ability to cross the [[blood–brain barrier]] and exert effects in the [[central nervous system]].<ref name="pmid33572109">{{cite journal | vauthors = Cojocariu SA, Maștaleru A, Sascău RA, Stătescu C, Mitu F, Leon-Constantin MM | title = Neuropsychiatric Consequences of Lipophilic Beta-Blockers | journal = Medicina | volume = 57 | issue = 2 | date = February 2021 | page = 155 | pmid = 33572109 | pmc = 7914867 | doi = 10.3390/medicina57020155 | doi-access = free }}</ref> Beta blockers with greater blood–brain barrier [[Vascular permeability|permeability]] can have both [[neuropsychiatric]] therapeutic benefits and [[side effect]]s, as well as adverse [[cognition|cognitive]] effects.<ref name="pmid33572109" /> Central nervous system-related side effects and risks of beta blockers may include [[fatigue (medical)|fatigue]], [[depression (mood)|depression]], [[sleep disorder]]s (namely [[insomnia]]) and [[nightmare]]s, [[visual hallucination]]s, [[delirium]], [[psychosis]], [[Parkinson's disease]], and [[falling (accident)|falling]].<ref name="pmid33572109" /> Conversely, central nervous system-related benefits of beta blockers may include prevention and treatment of [[migraine]], [[essential tremor]], [[akathisia]], [[anxiety]], [[post-traumatic stress disorder]], [[aggression]], and [[obsessive–compulsive disorder]].<ref name="pmid33572109" /> Most beta blockers are lipophilic and can cross into the brain, but there are a number of exceptions.<ref name="pmid33572109" /> Highly lipophilic beta blockers include [[penbutolol]], [[pindolol]], [[propranolol]], and [[timolol]], moderately lipophilic beta blockers include [[acebutolol]], [[betaxolol]], [[bisoprolol]], [[carvedilol]], [[metoprolol]], and [[nebivolol]], and low lipophilicity or hydrophilic beta blockers include [[atenolol]], [[carteolol]], [[esmolol]], [[labetalol]], [[nadolol]], and [[sotalol]].<ref name="pmid33572109" /> It is thought that highly lipophilic beta blockers are able to readily cross into the brain, moderately lipophilic beta blockers are able to cross to a lesser degree, and low lipophilicity or hydrophilic beta blockers are minimally able to cross.<ref name="pmid33572109" /> More lipophilic beta-blockers are known to suppress melatonin release by 50-80%.<ref>{{Cite journal |last1=Stoschitzky |first1=K. |last2=Sakotnik |first2=A. |last3=Lercher |first3=P. |last4=Zweiker |first4=R. |last5=Maier |first5=R. |last6=Liebmann |first6=P. |last7=Lindner |first7=W. |date=April 1999 |title=Influence of beta-blockers on melatonin release |url=https://pubmed.ncbi.nlm.nih.gov/10335905/ |journal=European Journal of Clinical Pharmacology |volume=55 |issue=2 |pages=111–115 |doi=10.1007/s002280050604 |issn=0031-6970 |pmid=10335905|s2cid=32317760 }}</ref><ref>{{Cite journal |last1=Tikhomirova |first1=O. V. |last2=Zybina |first2=N. N. |last3=Kozhevnikova |first3=V. V. |date=2022-05-01 |title=Effects of Prolonged Use of β-Adrenoblockers on Melatonin Secretion, Sleep Quality, and Vascular Brain Damage |url=https://doi.org/10.1007/s11055-022-01270-y |journal=Neuroscience and Behavioral Physiology |language=en |volume=52 |issue=4 |pages=500–504 |doi=10.1007/s11055-022-01270-y |s2cid=250708105 |issn=1573-899X}}</ref><ref>{{Cite journal |last1=Gehrman |first1=Philip R. |last2=Anafi |first2=Ron C. |date=October 2021 |title=Treatment of a patient with a circadian sleep-wake disorder using a combination of melatonin and metoprolol |journal=Journal of Clinical Sleep Medicine |language=en |volume=17 |issue=10 |pages=2121–2124 |doi=10.5664/jcsm.9410 |issn=1550-9389 |pmc=8494102 |pmid=34032203}}</ref> The preceding beta blockers also vary in their [[intrinsic sympathomimetic activity]] and [[beta-1 adrenergic receptor|β<sub>1</sub>-adrenergic receptor]] [[binding selectivity|selectivity]] (or cardioselectivity), resulting in further differences in pharmacological profiles and suitability in different contexts between them.<ref name="pmid33572109" />
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Beta blocker
(section)
Add topic